Sarcoma & GIST
News
FDA Panel to Assess Ridaforolimus, Pazopanib for Sarcoma
News
Primary GIST Carries Poorer Prognosis When Outside GI Tract
Major Finding: The 10% of patients whose primaries were outside the gastrointestinal tract had a 28% increased risk of death after adjustment for...
News
Neoadjuvant Therapy Improves Survival of Large Sarcomas in Extremities
Major Finding: Among patients with soft-tissue sarcomas of the extremities measuring longer than 5 cm, 3-year overall survival was 63% for those...